Ole Alexander Opdalshei introduces the role of the Norwegian Cancer Society within Norwegian cancer research, care services and information…

Ketil Widerberg of the Oslo Cancer Cluster highlights how Norway’s excellence in electronic health records can help the country stake out a position…

In recent years the US has seen an overall decease in cancer deaths thanks to innovative medicines and treatments. However, much work remains to be…

The completion of the Human Genome Project (HGP) in April 2003 with the publication of the first human genome sequence is probably one of the most…

There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the EU each year and cancer is set to become the region’s leading cause…

Below is a selection of top recent news from Mexican pharma and healthcare, including the healthcare reforms president Andres Manuel Lopez Obrador is…

Speaking at the 2020 European Cancer Forum in Brussels, MSD’s Deepak Khanna outlines the progress that the company is making at the forefront of…

The second edition of the European Cancer Forum was held in Brussels, Belgium on Tuesday, 29 January 2020. Hosted by MSD in collaboration with the…

PharmaBoardroom sat down with more than 25 biotech CEOs in China in 2019. We analyzed the contents of the interviews and found the following recurring…

Key stakeholders in Swedish pharma explain why Sweden's record on cancer care is the best in Europe and what more still needs to be done.…

With cancer now causing one in eight deaths globally and, in Europe, even outpacing serious cardiovascular conditions in terms of prevalence,…

Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The country's innovative pharma association has…